Breast cancer in men

被引:7
作者
Beyrouti, Mohamed Issam [1 ]
Beyrouti, Rahma [1 ]
Beyrouti, Ramez [1 ]
Ben Amar, Mohamed [1 ]
Affes, Nejmeddine [1 ]
Frikha, Foued [1 ]
Abid, Mohamed [1 ]
Mnif, Ha [2 ]
Ayadi, Lobna [2 ]
Ghorbel, Ali [1 ]
机构
[1] EPS Habib Bourguiba, Serv Chirurg Gen, Sfax 3029, Tunisia
[2] EPS Habib Bourguiba, Lab Anatomopathol, Sfax, Tunisia
来源
PRESSE MEDICALE | 2007年 / 36卷 / 12期
关键词
D O I
10.1016/j.lpm.2007.03.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Breast cancer in men is rare and most often occurs at or after the age of 60 years. Prognosis is poor when it is discovered at a late stage, as it often is in men, although it should be easier to detect because men hove so little breast tissue. The causal mechanism appears to depend on hormone metabolism abnormalities related to elevated estrogen or prolactin levels. A family history of breast cancer is found in 5-10% of cases. Infiltrating ductal carcinoma accounts for most cases (70-90%) of mole breast cancers. In situ but not invasive carcinoma is exclusively ductal and accounts for 7% of cases. Spread to lymph nodes is observed in 50-75% of cases. Immunohistochemical analysis shows that tumors ore positive for progesterone and estrogen receptors more frequently in men than women. Diagnosis is based on clinical examination, ultrasonography and mammography. Aspiration cytology often makes it possible to confirm the malignancy. Excisional biopsy with on immediate intraoperative pathology examination confirms Malignancy and makes wider excision possible during the some procedure.
引用
收藏
页码:1919 / 1924
页数:6
相关论文
共 61 条
[1]   Breast cancer in Japanese men: Does sex affect prognosis? [J].
Anan K. ;
Mitsuyama S. ;
Nishihara K. ;
Abe Y. ;
Iwashita T. ;
Ihara T. ;
Tamae K. ;
Ono M. ;
Toyoshima S. .
Breast Cancer, 2004, 11 (2) :180-186
[2]   ADJUVANT CHEMOTHERAPY IN MALES WITH CANCER OF THE BREAST [J].
BAGLEY, CS ;
WESLEY, MN ;
YOUNG, RC ;
LIPPMAN, ME .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (01) :55-60
[3]   Frequent amplification and overexpression of CCND1 in male breast cancer [J].
Bärlund, M ;
Kuukasjärvi, T ;
Syrjäkoski, K ;
Auvinen, A ;
Kallioniemi, A .
INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (06) :968-971
[4]   Breast cancer in the male: a report of 19 cases [J].
Benchellal, Z ;
Wagner, A ;
Harchaoui, Y ;
Huten, N ;
Body, G .
ANNALES DE CHIRURGIE, 2002, 127 (08) :619-623
[5]  
Beyrouti Mohamed I, 2003, Tunis Med, V81, P48
[6]  
BINES J, 1997, P ASCO, V16, P558
[7]   Screening-detected breast cancer in a man with BRCA2 mutation:: Case report [J].
Brenner, RJ ;
Weitzel, JN ;
Hansen, N ;
Boasberg, P .
RADIOLOGY, 2004, 230 (02) :553-555
[8]   Aromatase and breast cancer [J].
Brodie, A. ;
Sabnis, G. ;
Jelovac, D. .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2006, 102 (1-5) :97-102
[9]  
Buzdar Aman U, 2003, Oncology (Williston Park), V17, P1361
[10]   Imaging characteristics of malignant lesions of the male breast [J].
Chen, Lina ;
Chantra, Prem K. ;
Larsen, Linda H. ;
Barton, Premsri ;
Rohitopakarn, Montanan ;
Zhu, Elise Q. ;
Bassett, Lawrence W. .
RADIOGRAPHICS, 2006, 26 (04) :993-1006